Insights on the Organ Transplantation Global Market to 2026 – Technological Advancement and Increasing Issue Banks Present Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Organ Transplantation Market (2021-2026) by Treatment, Organ, Product, Transplant, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Organ Transplantation Market is estimated to be USD 12.95 Bn in 2021 and is expected to reach USD 22.1 Bn by 2026, growing at a CAGR of 11.28%.

Factors for driving the market are demand for tissue and organ plantation is high for organ failure treatment. Organ failure occurs due to various factors such as frivolous trauma, loss of blood, poisoning, drug abuse, etc. The increasing prevalence of renal disease, overconsumption of alcohol, and unhealthy diet have provided a push for the growth of the Organ Transplantation market. Huge population suffering from chronic illness and organ failure.

Treatment of failure contributing to the development and technological advancement and increasing issue banks are also boosting the market. A rise in demand for organ replacement, mainly kidney, heart, liver, is very high globally. High cost for transplantation including, the expensiveness of the accomplished services, the limited number of donors available, the number of failures that happen, hampers the market. An increasing incidence of organ failure creates tension among patients. The challenges are the Shortage of resources available in the market.

The Global Organ Transplantation Market is segmented based on Treatment, Organ, Product, Transplant, End User, and Geography.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Organ Transplantation Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using a Competitive Quadrant, Infogence’s proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Market Dynamics

Drivers

• High Demand for Tissue and Organ Plantation
• Increasing Prevalence of Renal Disease
• Large Population Suffering from Chronic Diseases

Restraints

• High Cost of Transplantation
• Increasing Incident of Organ Failure

Opportunities

• Treatment of Organ Failure Contributing to Growth
• Technological Advancement and Increasing Issue Banks
• The Rise in Demand of Organ Replacement

Challenges

• Shortage of Resources
• Large and Scarce Competition
• Impact of Domestic Tariffs

Companies Mentioned

• Novartis International AG
• Terumo Medical Corporation
• Transonic
• F. Hoffmann-La Roche Ltd.
• Astellas Pharma Inc.
• Preservation Solutions, Inc.
• OrganOX Limited
• Bio-Med Pvt. Ltd.
• Transplant Biomedical
• TransMedic Inc.
• Accord healthcare GmbH
• Sanofi
• Pfizer Inc.
• Veloxis Pharmaceuticals
• GlaxoSmithKline plc.
• Medtronic
• Terumo corporation
• AbbVie Inc.
• Stryker
• Zimmer Biomet
• Organdonor.gov
• NHS Blood and transplant
• 21st-century medicine
• Biolife solutions
• Teva pharmaceutical
• Veloxis pharmaceutical

For more information about this report visit https://www.researchandmarkets.com/r/b4s3uc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900